The relationship between mild cognitive impairment and postoperative delirium undergoing total knee arthroplasty: The

Bin Wang1, Chuanlin Mu1, Xinhui Tang2

  • 1Department of Anesthesiology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao, China.

Abstract

Insights

Mild cognitive impairment (MCI) is a risk factor for postoperative delirium (POD). Amyloid and tau pathologies may mediate the link between MCI and POD, offering prognostic insights for surgical patients.

Area of Science:

  • Neurosurgery
  • Geriatric Medicine
  • Anesthesiology

Background:

  • Surgery and anesthesia increase the risk of postoperative delirium (POD).
  • Mild cognitive impairment (MCI) is a potential predisposing factor for POD.
  • The relationship between MCI and POD, and its underlying mechanisms, require further investigation.

Purpose of the Study:

  • To investigate the association between mild cognitive impairment (MCI) and postoperative delirium (POD).
  • To determine if MCI influences POD development through core POD pathologies.
  • To explore the role of cerebrospinal fluid (CSF) biomarkers in this relationship.

Main Methods:

  • Enrolled 50-90 year old Chinese Han patients undergoing unilateral total knee arthroplasty with epidural anesthesia.
  • Assessed MCI pre-operation using Winblad's criteria.
  • Diagnosed POD post-operation using the Confusion Assessment Method (CAM) and Memorial Delirium Assessment Scale (MDAS).
  • Measured CSF biomarkers (T-tau, P-tau, Aβ42) via ELISA and performed causal mediation analyses.

Main Results:

  • POD incidence was 20.2%, with 32.5% in the MCI group and 12.4% in the non-MCI group.
  • MCI and elevated CSF T-tau and P-tau levels were risk factors for POD.
  • CSF Aβ42, Aβ42/T-tau, and Aβ42/P-tau levels were protective factors against POD.
  • Amyloid and tau pathologies partially explained the effect of MCI on cognition.

Conclusions:

  • Mild cognitive impairment (MCI) serves as a significant prognostic factor for postoperative delirium (POD).
  • Amyloid and tau protein pathologies may partially mediate the influence of MCI on POD.
  • These findings highlight potential therapeutic targets for preventing POD in at-risk patients.